Fol. Biol. 2017, 63, 42-51
https://doi.org/10.14712/fb2017063020042
Moringa olifeira Lam. Stimulates Activation of the Insulin-Dependent Akt Pathway. Antidiabetic Effect in a Diet-Induced Obesity (DIO) Mouse Model
References
1. 1997) Identification and characterization of two distinct intracellular GLUT4 pools in rat skeletal muscle: evidence for an endosomal and an insulin-sensitive GLUT4 compartment. Biochem. J. 325, 727-732.
< , J., Lavoie, L., Volchuk, A., Keller, S. R., Klip, A., Hundal, H. S. (https://doi.org/10.1042/bj3250727>
2. 2000) CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 14, 202-207.
< , C. A., Ribon, V., Kanzaki, M., Thurmond, D. C., Mora, S., Shigematsu, S., Bickel, P. E., Pessin, J. E., Saltiel, A. R. (https://doi.org/10.1038/35025089>
3. Brahmachari, G. (2011) Six bio-flavonoids with promising antidiabetic potentials: a critical survey. In Opportunity, Challenge and Scope of Natural Products in Medicinal Chemistry. Ed. V. K. Tiwari, pp. 187-212, Research Signpost, Kerala, India.
4. 1993) Prevalence of diabetes mellitus among the James Bay Cree of northern Quebec. CMAJ 3, 303-307.
, P., Robinson, E., Lavallee, C. (
5. 2007) Highfat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring) 15, 798-808.
< , R., Schölmerich, J., Bollheimer, L. C. (https://doi.org/10.1038/oby.2007.608>
6. Cano, N. B. D., Schneider, S. M., Vasson, M. P., Hasselmann, M., Leverve, X. (2007) Traité de nutrition artificielle de l’adulte. Springer-Verlag, Paris, France. (in French)
7. 2007) Effect of Sclerocarya birrea (Anacardiaceae) stem bark methylene chloride/ methanol extract on streptozotocin-diabetic rats. J. Ethnopharmacol. 110, 434-438.
< , T., Rakotonirina S. V., Tan P. V., Azay, J., Dongo, E., Kamtchouing, P., Cros, G. (https://doi.org/10.1016/j.jep.2006.10.020>
8. 2005) Transcriptional regulation of lipid metabolism by fatty acids: a key determinant of pancreatic β-cell function. Nutr. Metab. (Lond.) 5, 21-31.
, Z., Chan, C. B. (
9. 2006) Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases. Med. Sci. (Paris) 22, 381-388.
< , M., Taleux, N., Guigas, B., Horman, S., Beauloye, C., Andreelli, F., Bertrand, L., Viollet, B. (https://doi.org/10.1051/medsci/2006224381>
10. 1992) (K)-Epicatechin-3-galloyl ester: a secretagogue compound from the bark of Sclerocarya birrea. Planta Medica 58, 174-175.
< Peralta, J., Zarzuelo, A., Busson, R., Cobbaert, C., de Witte, P. (https://doi.org/10.1055/s-2006-961423>
11. 2008) Sclerocarya birrea [(A. Rich.) Hochst.] [Anacardiaceae] stem-bark ethanolic extract (SBE) modulates blood glucose, glomerular filtration rate (GFR) and mean arterial blood pressure (MAP) of STZ-induced diabetic rats. Phytomedicine 15, 699-709.
< , M., Kamadyaapa, D. R., Tufts, M., Chuturgoon, A. A., Musabayane, C. T. (https://doi.org/10.1016/j.phymed.2008.02.004>
12. 2003) Glucagon and regulation of glucose metabolism. Am. J. Physiol. Endocrinol. Metab. 4, E671-E678.
< , G. Z. B. (https://doi.org/10.1152/ajpendo.00492.2002>
13. 2005) Insulin-stimulated phosphorylation of the Akt substrate AS160 is impaired in skeletal muscle of type 2 diabetic subjects. Diabetes 6, 1692-1697.
< , H. K., Zierath, J. R., Kane, S., Krook, A., Lienhard, G. E., Wallberg-Henriksson, H. (https://doi.org/10.2337/diabetes.54.6.1692>
14. 2001) Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2, 282-286.
< , S. (https://doi.org/10.1093/embo-reports/kve071>
15. 2008) SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease. Int. J. Mol. Med. 21, 507-511.
, M., Higuchi, N., Kato, M, Kotoh, K., Yoshimoto, T., Fujino, T., Yada, M., Yada, R., Harada, N., Enjoji, M., Takayanagi, R., Nakamuta, M. (
16. 2010) Antidiabetic and free radicals scavenging potential of Euphorbia hirta flower extract. Indian J. Pharm. Sci. 72, 533-537.
< , S., Malhotra, R., Kumar, D. (https://doi.org/10.4103/0250-474X.73921>
17. 2006) Leads from Indian medicinal plants with hypoglycemic potentials. J. Ethnopharmacol. 106, 1-28.
< , P., Maiti, K., Mukherjee, K., Houghton, P. (https://doi.org/10.1016/j.jep.2006.03.021>
18. 1985) Dissociation of effects of insulin and contraction on glucose transport in rat epitrochlearis muscle. Am. J. Physiol. 249, C226-C232.
< , R., Karl I. E., Kipnis, D. M. (https://doi.org/10.1152/ajpcell.1985.249.3.C226>
19. 2003) Hypoglycemic effect of Sclerocarya birrea [(A. Rich.) Hochst.] [Anacardiaceae] stem-bark aqueous extract in rats. Phytomedicine 10, 675-681.
< , J. A. (https://doi.org/10.1078/0944-7113-00295>
20. 1994) Time course of adaptation to a highfat diet in obesity-resistant and obesity-prone rats. Am. J. Physiol. 267, 659-664.
, M. J., Knobel, S. M., Shahrokhi, K. A., Manzo, A. M., Hill, J. O. (
21. 1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 4, 537-544.
< , X. R., Li, G. W., Hu, Y. H., Wang, J. X., Yang, W. Y., An, Z. X., Hu, Z. X, Lin, J., Xiao, J. Z., Cao, H. B., Liu, P. A., Jiang, X. G., Jiang, Y. Y., Wang, J. P., Zheng, H., Zhang, H., Bennett, P. H., Howard, B. V. (https://doi.org/10.2337/diacare.20.4.537>
22. 1984) Increased muscle glucose uptake during contractions: no need for insulin. Am. J. Physiol. 6, E726-E731.
, T., Galbo, H., Richter, E. A. (
23. 1998) Peroxisome proliferatoractivated receptor α activation modulates cellular redox status, represses nuclear factor-κB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 273, 32833-32841.
< , M. E., Daynes, R. A. (https://doi.org/10.1074/jbc.273.49.32833>
24. 2002) Antidiabetic and hypolipidemic activity of Helicteres isora in animal models. J. Ethnopharmacol. 81, 343–349.
, C., Reeba, K., Mullangi, R., Sharma, V. M., Jagadheshan, H., Rao, Y. N. (
25. 2004) Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 31, 32345-32353.
< , V. T., Liu, Z. X., Qu, X., Elder, B. D., Bilz, S, Befroy, D., Romanelli, A .J., Shulman, G. I. (https://doi.org/10.1074/jbc.M313478200>
26. 2006) Selected plant species from the Cree pharmacopoeia of northern Quebec possess antidiabetic potential. Can. J. Physiol. Pharmacol. 84, 847-858.
< , D. C., Martineau, L. C., Leduc, C., Benhaddou-Andaloussi, A., Meddah, B., Harris, C., Burt, A., Fraser, M. H., Coonishish, J., Joly, E., Cuerrier, A., Bennett, S. A., Johns, T., Prentki, M., Arnason, J. T., Haddad, P. S. (https://doi.org/10.1139/y06-018>
27. 2013) Recent advances on novel dual-acting peroxisome proliferator-activated receptor α and γ agonists. Int. J. Pharm. Sci. Res. 4, 1644-1653.
, A. (
28. 2014) Intestinal α-glucosidase and some pancreatic enzymes inhibitory effect of hydroalcholic extract of Moringa stenopetala leaves. BMC Complement. Altern. Med. 14, 1472-1480.
< , A., Makonnen, E., Mekonnen, Y., Debella, A., Adisakwattana, S. (https://doi.org/10.1186/1472-6882-14-180>
29. 2004) Effect of green tea on blood glucose levels and serum proteomic patterns in diabetic (db/db) mice and on glucose metabolism in healthy humans. BMC Pharmacology 4, 18.
< , H., Ishizuka, M., Terasawa, M., Wu, J.B., Sasaoka, T., Kimura, I. (https://doi.org/10.1186/1471-2210-4-18>
30. 2010) Microvascular and macro-vascular complication of diabetes mellitus. IJPRIF 2, 1883-1892.
, M., Sreenivasulu, M., Chengaiah, B. (
31. 2002) Peroxisome proliferator-activated receptors (PPARs): from metabolic control to epidermal wound healing. Swiss Med. Wkly. 132, 83-91.
, W. (
32. 2001) GLUT4: a key player regulating glucose homeostasis? Insights from transgenic and knockout mice. Mol. Membr. Biol. 3, 205-211.
< , H., Zierath, J. (https://doi.org/10.1080/09687680110072131>
33. 2004) Global prevalence of diabetes. Diabetes Care 27, 1047-1053.
< , S., Roglic, G., Green, A., Sicree, R., King, H. (https://doi.org/10.2337/diacare.27.5.1047>
34. 1999) AMP-activated protein kinase, a metabolic master switch: possible roles in type 2 diabetes. Am. J. Physiol. 277, E1-E10.
, W. W, Hardie, D. G. (
35. 2002) Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J. Biol. Chem. 277, 19353-19357.
< , N., Shimano H., Hasty, A. H., Matsuzaka, T., Ide, T., Yoshikawa, T., Amemiya-Kudo, M., Tomita, S., Okazaki, H., Tamura, Y., Lizuka, Y., Ohashi, K., Osuga, J., Harada, K., Gotoda, T., Nagai, R., Ishibashi, S., Yamada, N. (https://doi.org/10.1074/jbc.M201584200>
36. 2006) Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPARα activators: clinical and experimental evidence. Arterioscler. Thromb. Vasc. Biol. 26, 977-986.
< , A., Gervois P., Pauletto, P., Fruchart, J. C., Staels, B. (https://doi.org/10.1161/01.ATV.0000204327.96431.9a>